Clinical Trials Logo

Clinical Trial Summary

Cyclic vomiting syndrome is a disorder characterized by nausea and vomiting, separated by periods without any symptoms. There is very little research on this field at this point and most doctors do not fully understand the disorder. The goal of this study is to assess how the stomach empties food. Participants will be asked to participate in this study because either (a) they have been diagnosed and/or treated for cyclic vomiting syndrome in the past, or (b) they are physically healthy. The study seeks to compare how a healthy person's stomach empties to how the stomach of someone with cyclic vomiting disorder empties.


Clinical Trial Description

Up to 14% of unexplained vomiting in adults is attributed to an under recognized and often misdiagnosed disorder termed cyclic vomiting syndrome (CVS). As CVS is better understood, gastroenterologists are increasingly recognizing the importance of timely diagnosis and early management for this chronic and debilitating disorder. Currently, the only gold standard diagnostic strategy involves evaluating clinical criteria set by the Rome Foundation, such as vomiting frequency and duration of episodes. Outside of these subjective criteria, no definitive and objective diagnostic strategy for cyclic vomiting syndrome exists.

Developing diagnostic strategies has been difficult given the exact etiology of CVS is still unknown. One physiologic theory includes rapid gastric emptying (GE)—or a dumping-like syndrome related to impaired gastric accommodation. A retrospective analysis observed rapid gastric emptying by standard 4-hour scintigraphic gastric emptying study in 80% of subjects, suggesting a relationship with CVS and rapid GE. In turn, rapid emptying has been hypothesized to relate with abnormal gastric accommodation - the reflex allowing storage of food through increased fundic volume. This physiologic abnormality can be readily and easily measured using non-invasive tools, but have never been tested in CVS. To explore this further, we aim to determine if CVS patients have abnormal gastric accommodation measured by nutrient drink test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03470181
Study type Observational
Source The Cleveland Clinic
Contact
Status Completed
Phase
Start date February 1, 2018
Completion date May 29, 2018

See also
  Status Clinical Trial Phase
Completed NCT04329637 - Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS N/A
Withdrawn NCT00728104 - The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS) N/A
Recruiting NCT05256160 - Cortical Excitability in Cyclic Vomiting Syndrome N/A
Recruiting NCT05961995 - Heartfulness Meditation Cyclic Vomiting Syndrome N/A
Completed NCT03434652 - Auricular Neurostimulation for Cyclic Vomiting Syndrome N/A
Completed NCT04645953 - Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome Phase 2
Completed NCT03295760 - Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children N/A
Terminated NCT05065567 - Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis Phase 2
Terminated NCT04721171 - Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome. N/A